NASDAQ:IBBiShares Nasdaq Biotechnology ETF Stock Price, Forecast & News

iShares Nasdaq Biotechnology ETF's stock was trading at $106.97 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, IBB shares have increased by 31.4% and is now trading at $140.57. View which stocks have been most impacted by Coronavirus.

iShares Nasdaq Biotechnology ETF declared a quarterly dividend on Wednesday, March 25th. Stockholders of record on Thursday, March 26th will be paid a dividend of $0.0554 per share on Tuesday, March 31st. This represents a $0.22 annualized dividend and a dividend yield of 0.16%. The ex-dividend date of this dividend is Wednesday, March 25th. View iShares Nasdaq Biotechnology ETF's dividend history.

iShares Nasdaq Biotechnology ETF shares split on the morning of Friday, December 1st 2017. The 3-1 split was announced on Tuesday, November 7th 2017. The newly minted shares were payable to shareholders after the market closes on Thursday, November 30th 2017. An investor that had 100 shares of iShares Nasdaq Biotechnology ETF stock prior to the split would have 300 shares after the split.

News stories about IBB stock have trended somewhat negative this week, InfoTrie reports. The research firm scores the sentiment of news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. iShares Nasdaq Biotechnology ETF earned a news impact score of -1.6 on InfoTrie's scale. They also gave media stories about the financial services provider a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the stock's share price in the next several days. View the latest news about iShares Nasdaq Biotechnology ETF.

Some companies that are related to iShares Nasdaq Biotechnology ETF include DNP Select Income Fund (DNP), Nuveen Municipal Value Fund (NUV), Adams Diversified Equity Fund (ADX), PIMCO Corporate&Income Opportunity Fund (PTY), Tri-Continental (TY), Gabelli Equity Trust (GAB), Royce Value Trust (RVT), Liberty All-Star Equity Fund (USA), Hercules Capital (HTGC), Boulder Growth & Income Fund (BIF), Tekla Healthcare Investors (HQH), Blackrock Muniyield Insured Fund (MYI), AllianceBernstein Global Hgh Incm Fd (AWF), Tortoise Energy Infrastructure (TYG) and Invesco Van Kampen Munpl Oprtnty Tr (VMO). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other iShares Nasdaq Biotechnology ETF investors own include NVIDIA (NVDA), Alibaba Group (BABA), Walt Disney (DIS), Netflix (NFLX), Bank of America (BAC), Tesla (TSLA), Cisco Systems (CSCO), Gilead Sciences (GILD), Micron Technology (MU) and Boeing (BA).

iShares Nasdaq Biotechnology ETF trades on the NASDAQ under the ticker symbol "IBB."

iShares Nasdaq Biotechnology ETF's stock is owned by a number of institutional and retail investors. Top institutional investors include Envestnet Asset Management Inc. (0.60%), Chesley Taft & Associates LLC (0.06%), M&R Capital Management Inc. (0.05%), EWG Elevate Inc. (0.04%), Burns J W & Co. Inc. NY (0.04%) and Bay Rivers Group (0.03%).

IBB stock was sold by a variety of institutional investors in the last quarter, including Fulton Bank N. A., Clarus Wealth Advisors, Chesley Taft & Associates LLC, Wiley BROS. Aintree Capital LLC, Burns J W & Co. Inc. NY, ELM Advisors LLC, and Private Trust Co. NA.

IBB stock was purchased by a variety of institutional investors in the last quarter, including Envestnet Asset Management Inc., EWG Elevate Inc., Platte River Wealth Advisors LLC, Tatro Capital LLC, M&R Capital Management Inc., Carroll Financial Associates Inc., N.E.W. Advisory Services LLC, and Tsfg LLC.

Shares of IBB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of IBB stock can currently be purchased for approximately $140.57.

iShares Nasdaq Biotechnology ETF has a market capitalization of $9.99 billion.